During the recent session, Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares were 0.94 million, with the beta value of the company hitting -0.11. At the last
In the last trading session, 8.25 million shares of the Lyra Therapeutics Inc (NASDAQ:LYRA) were traded, and its beta was -0.10. Most recently the company’s
In the last trading session, 3.43 million shares of the Lyra Therapeutics Inc (NASDAQ:LYRA) were traded, and its beta was -0.08. Most recently the company’s
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 4.32 million during the last session, with the company’s beta value hitting -0.12. At the close of
In the last trading session, 1.15 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched -0.04. With the company’s per share
In the latest trading session, 0.57 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched -0.04. With the company’s most recent
In recent trading session, Lyra Therapeutics Inc (NASDAQ:LYRA) saw 0.47 million shares changing hands at last check today with its beta currently measuring -0.03. Company’s
During the last session, Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares were 3.82 million, with the beta value of the company hitting -0.02. The 52-week high
In the last trading session, 1.62 million shares of the Lyra Therapeutics Inc (NASDAQ:LYRA) were traded, and its beta was -0.02. Most recently the company’s
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 1.11 million during the last session, with the company’s beta value hitting -0.02. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
